The Law Offices of Frank R. Cruz announces an investigation of Prestige Consumer Healthcare (“Prestige Consumer” or the “Company”) (NYSE: PBH) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON PRESTIGE CONSUMER HEALTHCARE (PBH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS.
What Is The Investigation About?
On May 13, 2026, Prestige Consumer announced fourth quarter and full year 2026 earnings, including that, “for fiscal ’26, revenues decreased 4.5% organically versus the prior year” and “[t]otal company adjusted gross margin of 55.6% for the year was approximately flat to 55.8% in the prior year.”
In the associated earnings call, the Company’s CEO Ron Lombardi revealed “in Q4, Clear Eyes sales were below expectations due to delayed shipments and production shutdowns ahead of line updates.”
On this news, shares of Prestige Consumer fell $5.88 per share, or 11.35%, to close at $45.93 on May 14, 2026.
Contact Us To Participate or Learn More:
If you purchased Prestige Consumer securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
The Law Offices of Frank R. Cruz,
2121 Avenue of the Stars, Suite 800,
Century City, California 90067
Call us at: 310-914-5007
Email us at: info@frankcruzlaw.com
Visit our website at: www.frankcruzlaw.com.
Follow us for updates on Twitter at twitter.com/FRC_LAW.
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260515783623/en/
Media gallery
